CVSI - CV Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
4.1600
-0.0400 (-0.95%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close4.2000
Open4.2750
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range4.0800 - 4.3500
52 Week Range1.3900 - 9.2000
Volume474,474
Avg. Volume1,053,161
Market Cap410.412M
Beta (3Y Monthly)-0.24
PE Ratio (TTM)N/A
EPS (TTM)-0.0020
Earnings DateJul 30, 2019 - Aug 5, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.50
Trade prices are not sourced from all markets
  • GlobeNewswire10 hours ago

    Groundbreaking Research Proves Efficacy of PlusCBD™ Oil in Sleep, Wellness and Weight-Loss Applications

    First-Ever Double-Blind, Randomized Study Titled, “Effects of a CBD-containing Supercritical Fluid Extract of Hemp on Markers of Optimal Wellness, Stress Resilience, and.

  • 5 Small-Cap Pot Stocks With Rising Profit Projections
    Motley Fool3 days ago

    5 Small-Cap Pot Stocks With Rising Profit Projections

    North American cannabis supply issues haven't been a problem for these marijuana stocks.

  • GlobeNewswire4 days ago

    CV Sciences, Inc. to Present at the Oppenheimer 19th Annual Consumer Conference

    LAS VEGAS, June 13, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products.

  • CBD leader CV Sciences jumps 10% on Kroger deal to sell CBD oil in 17 US states
    Yahoo Finance5 days ago

    CBD leader CV Sciences jumps 10% on Kroger deal to sell CBD oil in 17 US states

    Shares of CBD company CV Sciences jumped 10% on a deal with retailer Kroger to sell its oils in nearly 1,000 stores.

  • GlobeNewswire5 days ago

    CV Sciences, Inc. Announces New Distribution With Kroger and Expands Its Offering of Topical Products

    PlusCBD™ Oil Roll-On Launch at 945 Kroger Stores in 17 U.S. States LAS VEGAS, June 12, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or.

  • GlobeNewswire11 days ago

    CV Sciences Comments on FDA CBD Hearing

    Top hemp CBD Company urges FDA to swiftly develop regulations to separate an agricultural commodity from a controlled substance and ensure consumer safety LAS VEGAS, June 06,.

  • Barrons.com14 days ago

    Cannabis Legalization Has Taken a Couple of Big Steps Forward

    Illinois became the first state to approve approved recreational marijuana use for adults by legislature, as opposed to a voter referendum.

  • GlobeNewswire26 days ago

    CV Sciences, Inc. Applauds California Assembly Support of Hemp-derived CBD products through Unanimous Passing of AB 228

    CV Sciences, Inc. (CVSI) (the “Company”, “”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its industry-dominating brand,  PlusCBD Oil™, announces its full support of the California Assembly’s Appropriations Committee’s unanimous passing of Assembly Bill 228 last week. Authored by Assemblymember Cecilia Aguiar-Curry (D-Winters), Assembly Bill 228 would expressly permit the retail sale of hemp-derived CBD in foods and supplements, and also in topical applications.

  • GlobeNewswirelast month

    CV Sciences’ PlusCBD Oil™ Used in First Study Examining Clinical Benefit of CBD for Patients with PTSD

    CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, is pleased to announced that its industry-dominating PlusCBD Oil™ products were used in the first study to date examining the clinical benefit of CBD for the treatment of Post-Traumatic Stress Disorder (PTSD). The study, published in The Journal of Alternative and Complementary Medicine in April 2019, examined the effect of oral CBD administration on symptoms of PTSD in a series of 11 adult patients at an outpatient psychiatry clinic.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of CVSI earnings conference call or presentation 8-May-19 8:30pm GMT

    Q1 2019 CV Sciences Inc Earnings Call

  • GlobeNewswirelast month

    CV Sciences, Inc. Reports First Quarter 2019 Financial Results

    Record quarterly revenue Increased retail distribution by over 1,000 stores LAS VEGAS, May 08, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) ("CV Sciences" or the “Company”).

  • GlobeNewswirelast month

    CV Sciences, Inc. to Present at Upcoming Investor Conferences

    LAS VEGAS, May 07, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products.

  • CV Sciences, Inc. (CVSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks2 months ago

    CV Sciences, Inc. (CVSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    CV Sciences, Inc. (CVSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • ACCESSWIRE2 months ago

    There is No Slowdown Ahead for CBD Growth in 2019

    Not only has it transformed multi-billion-dollar industries including alcohol, health and wellness, cigarettes, and the retail industry, it's impacting food, too. Better, the U.S. FDA could provide a substantial boost to cannabis stocks in weeks. Lifestyle Delivery Systems Inc. (LDS)(LDSYF) just announced that its flagship product, Cannastrips will be presented at the Hall of Flowers (HoF) event.

  • GlobeNewswire2 months ago

    CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2019

    CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its first quarter 2019 ended March 31, 2019, after the stock market closes on Wednesday, May 8, 2019. The Company will hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day. The webcast of the conference call will be available on the Investor Relations section of the Company's website at https://ir.cvsciences.com/news-events and at http://public.viavid.com/index.php?id=134448.

  • ACCESSWIRE2 months ago

    With Strong Demand, More Top Retailers are Just Beginning to Sell CBD Products

    Neiman Marcus is pushing ahead with CBD sales at some of its stores and online. Simon Property Group is partnering with Green Growth Brands to open 108 stores in its malls just in 2019. CVS will carry a line of CBD products in eight states, including California, Illinois, Colorado, and Alabama.

  • Benzinga2 months ago

    Canadian Investors Can Light Up A New Cannabis ETF Focused On US Companies

    Horizons is the company behind the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ)(OTC: HMLSF), which is one of the world's largest cannabis ETFs. “HMUS will be the first ETF in the world that is solely focused on providing exposure to companies with significant business activities in, or significant exposure to, the United States marijuana or hemp industries,” according to a statement.

  • GlobeNewswire2 months ago

    CV Sciences, Inc. Appoints Deloitte & Touche LLP as Auditor

    LAS VEGAS, April 15, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products,.

  • ACCESSWIRE2 months ago

    Three Companies Giving Investor the Biggest Exposure to CBD Growth

    HOUSTON, TX / ACCESSWIRE / April 12, 2019 / According to the Brightfield Group, worldwide CBD sales are expected to soar from $591 million in 2018 to as high as $22 billion by 2022 - a compound growth rate of 147%. Some of those companies include Lifestyle Delivery Systems Inc. (CSE: LDS)(OTC: LDSYF), Charlotte's Web Holdings Inc. (CN: CWEB)(OTC: CWBHF), and CV Sciences Inc. (NASDAQ: CVSI). Lifestyle Delivery Systems Inc.'s (LDS)(LDSYF) wholly owned subsidiary, CSPA Group just entered into an agreement to provide Mbioteq with a minimum of 120 liters of 85% THC raw distillate oil per month.

  • GlobeNewswire2 months ago

    CV Sciences, Inc. Announces Distribution Expansion Into Food, Drug and Mass Channels

    LAS VEGAS, April 10, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products, is.

  • ACCESSWIRE2 months ago

    The Up-And-Coming Cannabis Producer That's About To Double Their Production Potential

    The illicit cannabis industry is estimated at $50 billion yearly, much of which will move out of the shadows and become a legal market in the coming years. One research firm estimates the legal trade could be worth $21 billion by 2021. Item 9 Labs (INLB) could be one of these as they finish a major expansion project on their Arizona cannabis cultivation and production facility, doubling capacity.

  • 3 Best Marijuana Stocks in March: Are They Buys Now?
    Motley Fool3 months ago

    3 Best Marijuana Stocks in March: Are They Buys Now?

    Spring forward in March? These three marijuana stocks did a lot more than that.

  • ACCESSWIRE3 months ago

    Cannabis Has an Energy Problem, CLSK Has the Solution

    HENDERSON, NV / ACCESSWIRE / March 26, 2019 / The electricity consumption of cannabis grow houses is staggering when compared to business and residential use. In 2015, the average electricity consumption ...

  • ACCESSWIRE3 months ago

    These Four Marijuana Stocks Could Test March Highs on Monday

    Leafbuyer Technologies Inc (OTC:LBUY), CV Sciences Inc (CVSI), MedMen Enterprises Inc (MMNFF) (MMEN.CN), and Terra Tech Corp (TRTC) represent 4 marijuana stocks leading the pack on Monday. More than ever, consumers depend on online resources to research the products they are interested in buying and, prior to Leafbuyer's platform, no reliable source existed for information on cannabis and related products. Leafbuyer Technologies Inc (OTC:LBUY) earlier this month announced that the total number of Greenlight platform users has reached nearly 80,000.

  • GlobeNewswire3 months ago

    CV Sciences, Inc. Appoints Joerg Grasser as New Chief Financial Officer

    LAS VEGAS, March 21, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products.